Scarred atrophic thyroid after I-131 therapy for Graves' disease documented at autopsy

Journal of the National Medical Association

Volumn 94, Issue 10, 2002, Pages 915-919

  Shih, Wei Jen ^a   Mitchell, Bonnie ^b   Schott, Jennifer C ^b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

AGED; ARTICLE; ATROPHY; CASE REPORT; CHEMICALLY INDUCED DISORDER; FATALITY; FIBROSIS; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MALE; PATHOLOGY; RADIATION EXPOSURE; THYROID GLAND;

AGED; ATROPHY; FATAL OUTCOME; FIBROSIS; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; THYROID GLAND;

EID: 0036777019     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Singer PA, Cooper DS, Elliot GL, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA. 1995;273:808-811.
2. Cooper DS. Treatment of thyrotoxicosis. In Braverman LE, Utiger RD, eds Werner and Ingbar's the Thyroid. 7th ed. Philadelphia: Lippincott-Reven: 713-733.
3. Franklyn JA. The management of hyperthyroidism. N Engl J Med. 1994;330:1731-1738.
4. Chiovato L, Santini F, Pinchera A. Treatment of hyperthyroism. Thyroid Int. 1995;2:3-23.
5. Willimas ED. Biological effects of radiation on the thyroid. In: Braverman LE, Utiger RD, eds Werner and Ingbar's the Thyroid. 7th ed. Philadelphia: Lippincott-Reven:421-436.
6. Peters H, Fisher C, Bogner U, Reiners C, Schleusener H. Reduction in thyroid volume after radioiodine therapy of Grave's hypertyroidsm: results of a prospective, randomized, muticenter study. Eur J Clin Invest. 1996;26:59-63.
7. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C, Pinchera A. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induce thyroid damage. J Clin Endocrinol Metab. 1998;83:2155.
8. Toft AD, Seth J, Unter WM, Irvine WJ. Plasma throtropin and serum-thyroxine in patients becoming hypothyroid in early months after I-131. Lancet. 1:704, 1974.
9. Toft AD: Comment: predicting hypothyroidism. Scot Med J. 23:263, 1978.
10. Sofa A, Skillern P. Treatment of hyperthyroidism with a large initial dose of sodium iodide I-131. Arch Intern Med. 1975; 135:673.
11. Nordyke R, Gilbert F. Optimal Iodine-131 dose for eliminating hypothyroids in Graves' disease. J Nucl Med. 32:411, 1991.
12. Wise P, Burnet R, Ahmad A: International radiodine ablation in Grave's disease. Lancet. I:1231, 1975.
13. Kendall-Taylor P. Keikr M, Ross W. Ablative radioiodine therapy for hyperthyroidism: long-term follow-up study. BMJ. 289:361, 1984.
14. Sridama V, Maureen M, Edwin L. Long term follows up study of compensated low-dose I-131 therapy for Graves' disease. N Eng. J Med. 311:426,1984.
15. Gayed I, Wendt J, Haynie T, Damesh D, Moore W. Timing for Repeated Treatment of Hyperthyroid Disease with Radioactive Iodine After Initial Treatment Failure. Clin Nucl Med. 26:1-5, 2001.